Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea-Reference-Cited by-同舟云学术

Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea

Published:2003-03 Issue:3 Volume:25 Page:890-903
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Goldstein Barry J.,Pans Miranda,Rubin Cindy J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference17 articles.

1. Pharmacologic therapy for type 2 diabetes mellitus;DeFronzo;Ann Intern Med,1999

2. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications;Porte;Diabetes Metab Res Rev,2001

3. National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus: Toward better patient outcomes and new roles for pharmacists;Hawkins;Pharmacotherapy,2002

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

5. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Stud (UKDPS) Group;Matthews;Diabetes Med,1998

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping Advantages and Challenges in Analytical Development for Fixed Dose Combination Products, a Review;Journal of Pharmaceutical Sciences;2024-08

2. A Review on Affordable Combinations in Type 2 Diabetes Care: Exploring the Cost-Effective Potential of Glipizide + Metformin and Glimepiride + Metformin + Pioglitazone;Cureus;2024-05-07

3. Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and Fed Conditions in Chinese Healthy Subjects: A Randomized, Open-Label, Crossover Study;Journal of Clinical Pharmacy and Therapeutics;2024-04-10

4. Progress in Analytical Techniques for Remogliflozin Etabonate, Vildagliptin And Metformin Hydrochloride: A Recently, Approved FDC;Current Pharmaceutical Analysis;2023-02

5. Choosing Medications for Weight Loss in Type 2 Diabetes Mellitus;Clinical Dilemmas in Diabetes;2021-11-05